In pursuit of both time and cost savings, as well as to mitigate the challenges associated with the stringent regulatory compliance, lack of technical expertise and access to advanced equipment, a number of drug developers prefer to outsource operations to benefit from the expertise of service providers, that claim to have the required competence and experience to provide fill / finish services in order to ensure the development of high-quality drug products.

The financial opportunity within the aseptic fill and finish services market has been analyzed across the following segments:

§  Type of Molecule

§  Small molecules

§  Biologics

§  Type of Packaging Container

§  Ampoules

§  Cartridges

§  Syringes

§  Vials

§  Type of Drug Product

§  Antibodies

§  Cell Therapies

§  Gene Therapies

§  Oligonucleotides

§  Recombinant Proteins

§  Vaccines

§  Other Drug Products

§  Target Therapeutic Area

§  Autoimmune disorders

§  Oncological Disorders

§  Cardiovascular Disorders

§  Infectious Diseases

§  Other Disorders

§  Scale Of Operation

§  Preclinical / Clinical

§  Commercial

§  Company Size

§  Large

§  Mid-sized

§  Small

§  Key Geographical Regions

§  North America

§  Europe

§  Asia-Pacific

§  Middle East and North Africa

§  Latin America

The Aseptic Fill Finish Market, 2023-2035 report features the following companies, which we identified to be key players in this domain:

§  BD Biosciences

§  AbbVie Contract Manufacturing

§  Aenova

§  APL

§  Asymchem

§  BD Biosciences

§  BioPharma Solutions

§  BioReliance

§  Boehringer Ingelheim BioXcellence

§  Catalent Biologics

§  Charles River Laboratories

§  CordenPharma

§  Delpharm

§  Fareva

§  Fresenius Kabi

§  GlaxoSmithKline

§  Hetero Drugs

§  Intas Pharmaceuticals

§  Lonza

§  Patheon

§  Pfizer CentreOne

§  Pierre Fabre

§  PiSA Farmaceutica

§  Plastikon Healthcare

§  Recipharm

§  Samsung Biologics

§  Sharp Services

§  Siegfried

§  Syngene

§  Takara Bio

§  Wacker Biotech

§  Wockhardt

§  WuXi Biologics

Table of Contents

1.         PREFACE

2.         EXECUTIVE SUMMARY

3.         INTRODUCTION

4.         ASEPTIC FILL AND FINISH SERVICE PROVIDERS LANDSCAPE

5.         BIOLOGICS FILL / FINISH SERVICE PROVIDERS LANDSCAPE

6.         SMALL MOLECULE FILL / FINISH SERVICE PROVIDERS LANDSCAPE

7.         COMPANY PROFILES: ASEPTIC FILL / FINISH SERVICE PROVIDERS IN NORTH AMERICA

8.         COMPANY PROFILES: ASEPTIC FILL / FINISH SERVICE PROVIDERS IN EUROPE

9.         COMPANY PROFILES: ASEPTIC FILL / FINISH SERVICE PROVIDERS IN ASIA-PACIFIC    

10.       PARTNERSHIPS AND COLLABORATIONS

11.       MARKET SIZING AND OPPORTUNITY ANALYSIS

12.       CASE STUDY: ROBOTICS IN PHARMACEUTICAL PACKAGING

13.       CASE STUDY: READY-TO-USE PACKAGING COMPONENTS FOR ASEPTIC FILL / FINISH

14.       CONCLUDING REMARKS

15.       EXECUTIVE INSIGHTS

16.       APPENDIX 1: TABULATED DATA

17.       APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

To view more details on this report, click on the link

https://www.rootsanalysis.com/reports/aseptic-fill-finish-market.html

Learn from experts:  do you know about these emerging industry trends?

SARM1 Inhibitors: A Novel Approach Against Neurodegenerative Disorders

TCR Therapies: An Emerging Therapeutic Modality

About Roots Analysis

Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Learn more about Roots Analysis consulting services: 

Roots Analysis Consulting - the preferred research partner for global firms

Contact:

Ben Johnson

+1 (415) 800 3415

Ben.johnson@rootsanalysis.com